Dear Senator Collins:
"On behalf of the Endocrine Society, thank you for introducing the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2023. The Society has over 18,000 members world-wide composed of scientists, physicians, nurses, and students, many with expertise in caring for people with diabetes. For years our members have expressed their alarm about the lack of access to affordable insulin. Consequently, improving insulin access and affordability is a top priority for the Endocrine Society and we commend you for your commitment to and leadership in finding a solution that will address both the out-of-pocket costs for consumers and rising price of this lifesaving medication."
